Next Article in Journal
Targeting the Adipose Tissue–Liver–Gut Microbiota Crosstalk to Cure MASLD
Previous Article in Journal
The Effect of Pollen on Coral Health
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Short-Term Exposure to Nitrogen Dioxide Modifies Genetic Predisposition in Blood Lipid and Fasting Plasma Glucose: A Pedigree-Based Study

1
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
2
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China
3
Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China
4
Fujian Provincial Center for Disease Control and Prevention, Fuzhou 350012, China
5
Department of Hygiene, Nanjing Country Center for Disease Control and Prevention, Nanjing 363600, China
6
Key Laboratory of Reproductive Health, Ministry of Health, Beijing 100191, China
7
Center for Public Health and Epidemic Preparedness & Response, Peking University, Beijing 100191, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Biology 2023, 12(12), 1470; https://doi.org/10.3390/biology12121470
Submission received: 8 October 2023 / Revised: 13 November 2023 / Accepted: 24 November 2023 / Published: 27 November 2023

Abstract

:

Simple Summary

This study aims to explore the effects of short-term exposure to nitrogen dioxide on blood lipids and fasting plasma glucose, as well as the interaction effects with genetic factors. This topic is important as it can reveal changes in gene expressions across different environmental levels, providing insights for subsequent analyses of loci-specific interaction effects and facilitating the interpretation of published studies on specific gene interactions. The results provide new evidence on the associations between nitrogen dioxide and blood lipids or fasting plasma glucose, which are crucial risk factors for cardiovascular disease and diabetes. In addition, we found a potential interaction between genotype and nitrogen dioxide in lipids and fasting plasma glucose, suggesting that future studies could prioritize nitrogen dioxide exposure if they can identify specific genetic variants behind the genotype–environment interactions that affect lipids and fasting plasma glucose.

Abstract

(1) Background: Previous studies suggest that exposure to nitrogen dioxide (NO2) has a negative impact on health. But few studies have explored the association between NO2 and blood lipids or fasting plasma glucose (FPG), as well as gene–air pollution interactions. This study aims to fill this knowledge gap based on a pedigree cohort in southern China. (2) Methods: Employing a pedigree-based design, 1563 individuals from 452 families participated in this study. Serum levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC), and FPG were measured. We investigated the associations between short-term NO2 exposure and lipid profiles or FPG using linear mixed regression models. The genotype–environment interaction (GenoXE) for each trait was estimated using variance component models. (3) Results: NO2 was inversely associated with HDLC but directly associated with TG and FPG. The results showed that each 1 μg/m3 increase in NO2 on day lag0 corresponded to a 1.926% (95%CI: 1.428–2.421%) decrease in HDLC and a 1.400% (95%CI: 0.341–2.470%) increase in FPG. Moreover, we observed a significant genotype–NO2 interaction with HDLC and FPG. (4) Conclusion: This study highlighted the association between NO2 exposure and blood lipid profiles or FPG. Additionally, our investigation suggested the presence of genotype–NO2 interactions in HDLC and FPG, indicating potential loci-specific interaction effects. These findings have the potential to inform and enhance the interpretation of studies that are focused on specific gene–environment interactions.

1. Introduction

Air pollution poses a significant and pervasive threat to global public health, contributing to 7.6% of all fatalities in 2015 [1]. Notably, a substantial proportion of the air pollution-related deaths in China are attributable to cardiovascular diseases (CVD) [2]. Given that CVDs stand as the leading cause of mortality globally, accounting for 32% of all deaths worldwide [3], we need to enhance our understanding of the intricate relationship between air pollution and the common risk factors associated with CVD, which is the key to advancing strategies for prevention and treatment.
Previous research has found that lipid and blood glucose levels could explain the relationship between air pollution and CVD [4,5,6,7,8,9,10]. For instance, Cai et al. found that a one-quartile interval increase in PM10 was associated with a 1.9% increase in TG [4]. Another study based on the NHANES cohort also found that elevated PM10 concentrations were associated with raised TG and TC levels [5]. A longitudinal study from China found that PM10 was associated with elevated blood glucose concentrations [6]. All of this evidence suggests a possible link between air pollution and cardiometabolic disease risk [4]. On the other hand, NO2, a potent atmospheric pollutant strongly associated with CVD, is a brown/orange irritant radical gas present in the environment. Common environmental sources of NO2 include mobile emissions, fuel combustion, industrial processes, and fires [11,12]. One plausible explanation for the association between NO2 and CVD is that NO2 induces abnormalities in lipid [7,8] and glucose [6] metabolism. Extensive evidence from animal studies support this claim, demonstrating a connection between air pollution and disrupted lipid profiles and elevated blood glucose levels [13,14]. Nevertheless, the body of population-based evidence on this topic remains both insufficient and inconsistent [8]. Furthermore, while much of the research on air pollution and its impact on lipid and glucose metabolism primarily focuses on airborne particulate matter, relatively fewer studies delve into the effects of gaseous pollutants like NO2.
Genetic factors also play a crucial role in lipid and glucose metabolism. Previous studies have estimated the heritability of lipid profiles [15,16,17] and fasting plasma glucose (FPG) levels [18,19]. Neglecting genetic influences or the genetic diversity across different populations might be one of the potential reasons for the inconsistent findings when investigating the connection between air pollution and dyslipidemia or hyperglycemia [20,21]. It is vital to discern whether susceptibility to adverse environmental exposures is genetically determined, a concept known as gene–environment interactions [22], and to elucidate the specific nature of these interactions. Such insights can aid in stratifying populations for targeted interventions. Both population-based and family-based studies have revealed interactions between inhaled particles and specific genetic variants concerning blood lipid levels, blood pressure, and blood glucose [20,21,23,24,25]. However, there is a scarcity of research exploring the impact of gene–NO2 interactions on blood lipids and FPG.
On the other hand, before delving into gene–environment interactions, we need quantitative genetics to determine whether traits are influenced by genotype–environment interactions (GenoXE). This preliminary step, often overlooked in practice, is essential as it helps establish the groundwork for subsequent investigations centered on specific environmental exposures and genetic loci. Unfortunately, this is rarely pursued due to the lack of adequately characterized cohorts with genealogical data [26]. GenoXE pertains to the interaction of overall additive genetic effects with environmental factors, meaning that the overall genetic influence on individual phenotypes varies across different levels of environmental exposures [27]. Importantly, this approach can be executed without the need for genotyping data but with a pedigree-based design.
Accordingly, the present study was undertaken to investigate the associations between NO2 exposure and lipid profiles as well as FPG levels. Furthermore, our analysis was conducted using extended pedigrees, allowing us to identify genotype–NO2 interactions. This approach lays the foundation for subsequent investigations focused on analyzing interaction effects at specific genetic loci and aids in the interpretation of previously published studies that delve into locus-specific interactions.

2. Materials and Methods

2.1. Study Population

We gathered data during the baseline survey of the Fujian Tulou Pedigree-based Cohort Study (FTPC), which was conducted between August 2015 and December 2017. The Fujian Tulous represent traditional Chinese rural dwelling styles in southeastern coastal China. Residents in this area organize themselves independently based on their family lineages, with a single surname predominating the population living in Tulous of various architectural forms. These Tulou pedigrees are typically expansive and characterized by intricate kinship ties, which facilitates the recruitment of more than three generations of family members—a practice rarely observed in other regions of China. Detailed information on the FTPC was reported in previous study [28]. Ultimately, our study included 452 families, comprising a total of 1563 study subjects. The study was approved by the Medical Research Ethics Committee of the Peking University Health Science Center. Informed consent was obtained before their participation in the study. The study was conducted in accordance with the Declaration of Helsinki.

2.2. Air Pollutant Data

We acquired air pollutant data, including the 24 h average concentrations of NO2, particulate matter (PM2.5 and PM10), carbon monoxide (CO), and ozone (O3), in Zhangzhou City, Fujian Province, spanning from 1 August 2015 to 31 December 2017. These data were sourced from the National Air Pollution Monitoring System. The national standard monitoring station is equipped with 24 h automatic monitoring instruments for NO2 concentrations. Daily average concentrations were computed for our analysis. It is noteworthy that the monitoring data have been demonstrated to be a reliable representation of population exposure to air pollution in China [29,30]. A map illustrating the site of the Fujian Tulou Pedigree-based Cohort study and the locations of air pollutant monitors can be found in the Supplementary Materials online, Figure S1.

2.3. Measurements

All participants underwent in-person interviews, physical examinations, and biochemical measurement by trained and certified investigators. A structured questionnaire was applied to collect basic demographic characteristics (age, sex, education), lifestyle information (smoking, alcohol drinking, physical activity, vegetable and fruit intake, whole-grain intake, and meat intake), and medication history (antihypertensive drugs, antidiabetic drugs, antihyperlipidemic drugs). Anthropometric variables, including height (cm) and weight (kg), were measured by trained technicians according to standard procedures. Body mass index (BMI) was then calculated as weight (kg) divided by squared height (m2). Overnight fasting venous blood (at least 8 h) was collected from participants for measuring their blood lipid levels, including TC, TG, LDLC, and HDLC, as well as their FPG levels. Blood specimens were processed and stored in Eppendorf tubes at the examination center, and sera were stored at −80 °C.

2.4. Statistical Analysis

We investigated the short-term relationships between air pollutants and lipid profiles or fasting plasma glucose (FPG) using four linear mixed models, each with distinct sets of adjusted covariates.
In Model 1, we controlled for age, sex, body mass index (BMI), and education level. Additionally, due to the pedigree-based design, we introduced family ID as a random effect in the model to account for correlations among individuals within families. Model 2 extended the adjustments to include factors such as smoking, alcohol consumption, physical activity, and dietary habits, encompassing the intake of fresh fruits and vegetables, whole grains, and meat, and tea consumption. In Model 3, we expanded our adjustments to encompass medication history, building upon the covariates considered in Model 2. In Model 4, we further incorporated the concentrations of particulate matter (PM2.5 and PM10), carbon monoxide (CO), and ozone (O3) based on the adjustments made in Model 3, creating the whole model. Recognizing the potential delayed associations, we considered different lag structures, ranging from lag0 to lag2, in our analysis. To estimate cumulative associations, we used moving averages across the lag periods, extending from mv01 (moving average concentrations of lag0 and lag1) to mv02 (moving average concentrations of lag0 to lag2). The results were presented as percentage changes in blood lipid levels or FPG and the associated 95% confidence intervals (CIs) for each 1 μg/m3 increase in NO2 concentration.
The genotype–environment interaction for each trait was estimated using maximum likelihood-based variance component models implemented in SOLAR (version 9.0.0). The variance of each phenotype (δ2) was partitioned into two components: additive genetic factors and environmental factors. Heritability (h2) was defined as the ratio of the residual variance of the trait resulting from additive genetic factors (   δ g 2 ) compared to the total residual phenotypic variance (δ2). The genotype–environment interaction estimates the relative contributions of genes to trait variance across different environments [27]. The additive genetic component, as a function of environmental exposure level, has been previously defined and expressed as δ g 2 = exp ( α g + γ g ( e i e ¯ ) ) , where e i is the environmental exposure level to which individual i is exposed, while e ¯ is the average environmental exposure level, and α g and γ g are both parameters to be estimated. If there is a genotype–environment interaction, then γ g is not equal to zero, implying that the heritability of the trait changes at different levels of an environmental exposure. All statistical tests were two-sided, and p < 0.05 was considered statistically significant. R 4.1.2 was used for data analysis and results output.

3. Results

3.1. Basic Characteristics

Table 1 provides an overview of the essential characteristics of the study participants. Between August 2015 and December 2017, a total of 1563 individuals, with an average age of 57.23 years, were included in our study. Of the participants, 43.57% were male. The mean concentrations of key parameters, including TG, TC, HDLC, LDLC, and FPG, were 1.75 mmol/L, 5.02 mmol/L, 1.31 mmol/L, 3.01 mmol/L, and 5.64 mmol/L, respectively.
Table 2 shows the distribution of daily NO2 concentrations. The NO2 data are matched to the date of the blood sample collection. Throughout the study period, the means of NO2 concentration were 27.48 μg/m3 (SD: 12.05 μg/m3), 27.45 μg/m3 (SD: 11.49 μg/m3), and 28.17 μg/m3 (SD: 11.18 μg/m3) for the day of blood draw (lag0), the previous day (lag1), and two days before the investigation (lag2), respectively. We also calculated the moving average concentrations for lag0 and lag1 (mv01) and the moving average concentrations from lag0 to lag2 (mv02), which were 27.47 μg/m3 (SD: 11.22 μg/m3) and 27.70 μg/m3 (SD: 10.64 μg/m3), respectively.

3.2. Association of NO2 with Blood Lipids and FPG

The impacts of NO2 concentration on lipid and FPG levels are detailed in Table 3 and Figure 1. A noteworthy reduction in HDLC was evident with rising NO2 levels in each lag structure (p < 0.05). We also identified a positive link between NO2 concentration and TG across most lag structures. Furthermore, an increase of 1 μg/m3 in NO2 was statistically linked to a 1.400% (0.341%, 2.470%) rise in FPG on day lag0. No significant associations were observed for TC and LDLC, although the point estimates indicated potential effects of increased NO2. Additionally, we noted variability in the lag effect of NO2 on lipids and glucose among different phenotypes. For TG, the lag effect of NO2 was more pronounced, showing significantly larger increments on days lag 2 and lag 1 compared to day lag 0. In contrast, with HDLC and GLU, the association with NO2 was most robust on day lag 0. To verify the robustness of these findings and explore potential interactions, we conducted stratified analyses based on sex, age, and BMI, which consistently upheld the results (Supplementary Materials online, Tables S1–S3).

3.3. Genotype–NO2 Interaction Effects on Blood Lipid Levels and FPG

The results of genotype–NO2 interactions are depicted in Figure 2. Even after accounting for various covariates, we identified a noteworthy genotype–NO2 interaction in both HDLC and FPG across all lag structures (p < 0.05). In the case of HDLC (Supplementary Materials online, Figure S2) and FPG (Supplementary Materials online, Figure S3), the additive genetic effects displayed a diminishing trend as the NO2 concentration increased, indicating a concurrent reduction in heritability.

4. Discussion

The present study provides new insights into the connections between NO2 and blood lipids or FPG, the critical risk factors for cardiometabolic diseases. In our investigation, elevated NO2 levels were related to higher TG and FPG, while also being associated with reduced HDLC. Furthermore, we discovered a potential interaction between genetic variations as a whole and NO2 concerning HDLC and FPG.
In partial alignment with prior research, our study unveiled a relationship between heightened NO2 concentrations and a reduction in HDLC. A survey conducted in urban areas of China reported that every 10 μg/m3 increase in NO2 corresponded to a 1.6% decrease in HDLC [31]. Similarly, findings from a study in South Korea produced analogous results [32]. Additionally, we established that NO2 levels are associated with decreased HDLC levels in Chinese adults aged 30–79 [33]. Moreover, our study suggested a positive association between NO2 and TG, which aligns with the findings of Yang et al., who observed a 6.0% increase in TG for every 10 μg/m3 rise in NO2 [31]. Furthermore, our study identified a positive trend in the associations of NO2 with LDLC and TC, although not statistically significant. These findings have generated controversy in prior studies. Evidence from a Chinese multi-ethnic cohort study demonstrated that heightened NO2 levels significantly elevated TC and LDLC [33]. Conversely, results from another study indicated that increased NO2 was linked to higher TC but not LDLC [34]. Simultaneously, we also identified a noteworthy positive relationship between NO2 and FPG, particularly evident in lag0 and mv02, hinting at a possible delayed effect. These observations align with previous research that has illuminated the glycemic impacts of air pollution [6,35,36,37]. Furthermore, several cohort studies have substantiated the association between NO2 exposure and an increased risk of diabetes [37,38].
The inconsistencies observed in these findings can be attributed to differences in study populations, air pollution levels, the duration of exposure, the accuracy of exposure, and outcome measurements. Additionally, inherent residual confounding variables in observational studies may have contributed to these variations, including confounders related to diet, physical activity, occupation, and indoor environment. Specifically, our study site is situated in a rural area, where the dietary patterns of the study population are mainly herbivorous, with lower meat consumption compared to urban populations [39,40]. People in rural areas typically burn straw, wood, or coal for cooking, as opposed to using cleaner energy sources, potentially leading to elevated NO2 levels in residential areas. Furthermore, residents in rural areas tend to have higher levels of physical activity, which can impact blood lipid profiles, but may also result in increased inhalation of air pollutants, leading to higher exposure levels. This complex interplay of various exposure sources and diverse lifestyles within the rural population complicates the association between NO2 and blood lipids. Therefore, our findings underscore the need for further exploration in the future to gain a more comprehensive understanding of these intricate relationships.
Genotype–environment interactions were also a notable focus of the current study. We observed a statistically significant interaction between genetic effects and NO2. The overall additive genetic effect gradually diminished as NO2 concentrations increased, signifying a concurrent reduction in the influence of genetic factors. This phenomenon may be attributed to the cumulative and escalating impact of environmental exposure as NO2 concentrations rise, a trend that has been substantiated in previous research [41]. Our findings underscored the importance of future studies that concentrate on identifying specific genetic variants that play a role in gene–environment interactions, particularly regarding the exposure to NO2 and its effects on blood lipids or FPG.
The underlying biological mechanism through which air pollution influences blood lipids and FPG remains a subject of ongoing investigation. A prevailing hypothesis suggests that air pollutants induce changes in blood lipids and FPG by inciting oxidative stress and triggering systemic inflammation [38,42,43]. These alterations in oxidative stress are particularly pronounced in the case of HDLC [44]. The inflammatory hypothesis regarding the impact of air pollution on FPG primarily targets adipose tissue [6,38]. Inflammation within adipose tissue can lead to an increased pro-inflammatory-to-anti-inflammatory macrophage ratio, potentially disrupting insulin signaling and contributing to insulin resistance [45]. Another potential pathway through which changes in FPG may occur is that air pollution directly affects insulin resistance [46]. Likewise, there might be pathways linked to DNA methylation that enable air pollution to influence blood lipid levels. Prior studies have established connections between air pollutants and DNA methylation levels in specific genes associated with lipid metabolism and inflammatory responses [47,48,49]. These findings partially elucidate the results of the genotype–NO2 interaction. Nonetheless, the precise mechanism necessitates further exploration.
To the best of our knowledge, the current study is the first examining genotype–NO2 interactions for cardiometabolic traits to be reported, which provided clues to identify underlying genetic variants in blood lipids and FPG. In addition, the use of a pedigree-based design was also a strength. Owing to the Tulous’ unique architectural forms, special culture, and remote geographical location, native residents are isolated from other ethnic populations, resulting in their homogenous genetic backgrounds. Therefore, the population stratification will be better controlled in this pedigree-based cohort. This study also has some limitations. First, although we used air pollution data from a few days prior to explore the short-term effects, it was still a cross-sectional study with weak causal inference ability. Second, we used fixed-site air pollution monitoring data rather than individual exposures, as detailed home address information was not available, which might have led to some degree of measurement error. Third, although we adjusted for a number of confounders, residual confounding from unknown and unmeasured sources might be present. Finally, the study was based on a population from the Tulou pedigrees in southern China, which might have affected the generalizability of the results to other populations, yet the internal validity of the study remains significant. In the future, the ongoing prospective follow-up and expansion of the Fujian Tulou Pedigree-based Cohort Study will enable us to examine the long-term effect of nitrogen dioxide on blood lipids and glucose levels. Building on the current findings, we aspire to conduct comprehensive genetic investigations to unravel the interactions between specific genes and the nitrogen dioxide exposure. This endeavor aims to provide valuable insights for more precise strategies for the prevention and management of cardiovascular diseases in the years to come.

5. Conclusions

In conclusion, this study revealed significant associations between NO2 exposure and alterations in blood lipid profiles and glucose levels, with NO2 being associated with elevated TG and FPG, as well as reduced HDLC. Furthermore, the results highlighted the importance of considering genotype–environment interaction effects involving genetic factors and NO2 exposure on blood lipid and FPG levels. The presence of genotype–NO2 interactions provided the basis for subsequent studies focusing on analyzing the interaction effects of specific genetic loci with NO2 and helped to explain the results of previously published studies.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/biology12121470/s1, Table S1: Percentage changes with 95% confidence intervals (95% CIs) in TG, TC, LDLC, HDLC, and FPG associated with per 1 μg/m3 increase in NO2 for different lag structures among population stratified by sex; Table S2: Percentage changes with 95% confidence intervals (95% CIs) in TG, TC, LDLC, HDLC, and FPG associated with per 1 μg/m3 increase in NO2 for different lag structures among population stratified by age group; Table S3: Percentage changes with 95% confidence intervals (95% CIs) in TG, TC, LDLC, HDLC, and FPG associated with per 1 μg/m3 increase in NO2 for different lag structures among population stratified by BMI; Figure S1: Map of Fujian Tulou Pedigree-based Cohort study site and air pollutant monitoring locations; interactions of genotype by NO2 on HDLC in different lag structures; Figure S2: Interactions of genotype by NO2 on HDLC in different lag structures; Figure S3: Interaction effects of genotype with NO2 on FPG in different lag structures.

Author Contributions

H.G.: Conceptualization, Methodology, Software, Writing—Original Draft Preparation; M.W.: Writing—Review and Editing, Funding Acquisition; Y.Y. (Ying Ye): Funding Acquisition, Supervision; C.H.: Investigation, Supervision; S.W.: Formal Analysis; H.P.: Formal Analysis; X.W. (Xueheng Wang): Formal Analysis; M.F.: Formal Analysis; T.H.: Formal Analysis; X.W. (Xiaoling Wu): Investigation; X.H.: Investigation; Y.Y. (Yansheng Yan): Investigation, Project Administration; K.Z.: Investigation, Project Administration; T.W.: Resources, Study Design, Data Curation, Writing—Review and Editing, Supervision, Funding Acquisition; L.L.: Resources, Supervision, Study Design, Writing—review and editing, Funding Acquisition, Project Administration. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Open-End Fund of the China CDC Key Laboratory of Environment and Population Health (Grant No. 2022-CKL-02), Special Funds for Health and Scientific Research on Public Welfare (Grant No. 201502006, TW), the Fujian Provincial Health Technology Project (Grant No. 2020CXB009, TW), the Natural Science Foundation of Fujian Province, China (Grant No. 2021J01352), the China Postdoctoral Science Foundation (Grant No. BX2021021, MYW), and the Peking University Outstanding Discipline Construction Project of Epidemiology and Biostatistics (LML, TW).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Peking University Health Science Center.

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

The data used in this study are available from the corresponding authors upon reasonable request.

Acknowledgments

We appreciate the participation of the individuals who made this study possible. We appreciate Yixin Li, Hanyu Zhang, Jin Jiang, and Bohao Ma for their valuable comments on our work.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cohen, A.J.; Brauer, M.; Burnett, R.; Anderson, H.R.; Frostad, J.; Estep, K.; Balakrishnan, K.; Brunekreef, B.; Dandona, L.; Dandona, R.; et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: An analysis of data from the Global Burden of Diseases Study 2015. Lancet 2017, 389, 1907–1918. [Google Scholar] [CrossRef] [PubMed]
  2. Zhou, M.; Wang, H.; Zeng, X.; Yin, P.; Zhu, J.; Chen, W.; Li, X.; Wang, L.; Wang, L.; Liu, Y.; et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019, 394, 1145–1158. [Google Scholar] [CrossRef] [PubMed]
  3. GBD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392, 1736–1788. [Google Scholar] [CrossRef] [PubMed]
  4. Cai, Y.; Hansell, A.L.; Blangiardo, M.; Burton, P.R.; De Hoogh, K.; Doiron, D.; Fortier, I.; Gulliver, J.; Hveem, K.; Mbatchou, S.; et al. Long-term exposure to road traffic noise, ambient air pollution, and cardiovascular risk factors in the HUNT and lifelines cohorts. Eur. Heart J. 2017, 38, 2290–2296. [Google Scholar] [CrossRef] [PubMed]
  5. Shanley, R.P.; Hayes, R.B.; Cromar, K.R.; Ito, K.; Gordon, T.; Ahn, J. Particulate Air Pollution and Clinical Cardiovascular Disease Risk Factors. Epidemiology 2016, 27, 291–298. [Google Scholar] [CrossRef] [PubMed]
  6. Chen, L.; Zhou, Y.; Li, S.; Williams, G.; Kan, H.; Marks, G.B.; Morawska, L.; Abramson, M.J.; Chen, S.; Yao, T.; et al. Air pollution and fasting blood glucose: A longitudinal study in China. Sci. Total Environ. 2016, 541, 750–755. [Google Scholar] [CrossRef]
  7. Wu, X.M.; Basu, R.; Malig, B.; Broadwin, R.; Ebisu, K.; Gold, E.B.; Qi, L.; Derby, C.; Green, R.S. Association between gaseous air pollutants and inflammatory, hemostatic and lipid markers in a cohort of midlife women. Environ. Int. 2017, 107, 131–139. [Google Scholar] [CrossRef]
  8. Gaio, V.; Roquette, R.; Dias, C.M.; Nunes, B. Ambient air pollution and lipid profile: Systematic review and meta-analysis. Environ. Pollut. 2019, 254 Pt B, 113036. [Google Scholar] [CrossRef]
  9. Cosselman, K.E.; Navas-Acien, A.; Kaufman, J.D. Environmental factors in cardiovascular disease. Nat. Rev. Cardiol. 2015, 12, 627–642. [Google Scholar] [CrossRef]
  10. Li, S.; Liu, Z.; Joseph, P.; Hu, B.; Yin, L.; Tse, L.A.; Rangarajan, S.; Wang, C.; Wang, Y.; Islam, S.; et al. Modifiable risk factors associated with cardiovascular disease and mortality in China: A PURE substudy. Eur. Heart J. 2022, 43, 2852–2863. [Google Scholar] [CrossRef]
  11. Goshua, A.; Akdis, C.A.; Nadeau, K.C. World Health Organization global air quality guideline recommendations: Executive summary. Allergy 2022, 77, 1955–1960. [Google Scholar] [CrossRef] [PubMed]
  12. Delfino, R.J.; Staimer, N.; Vaziri, N.D. Air pollution and circulating biomarkers of oxidative stress. Air Qual. Atmos. Health 2011, 4, 37–52. [Google Scholar] [CrossRef] [PubMed]
  13. Sun, Q.; Zhang, G.; Chen, R.; Li, R.; Wang, H.; Jiang, A.; Li, Z.; Kong, L.; Fonken, L.K.; Rajagopalan, S.; et al. Central IKK2 Inhibition Ameliorates Air Pollution-Mediated Hepatic Glucose and Lipid Metabolism Dysfunction in Mice with Type II Diabetes. Toxicol. Sci. 2018, 164, 240–249. [Google Scholar] [CrossRef] [PubMed]
  14. Ge, C.X.; Qin, Y.T.; Lou, D.S.; Li, Q.; Li, Y.Y.; Wang, Z.M.; Yang, W.W.; Wang, M.; Liu, N.; Wang, Z.; et al. iRhom2 deficiency relieves TNF-α associated hepatic dyslipidemia in long-term PM2.5-exposed mice. Biochem. Biophys. Res. Commun. 2017, 493, 1402–1409. [Google Scholar] [CrossRef] [PubMed]
  15. Pilia, G.; Chen, W.M.; Scuteri, A.; Orrú, M.; Albai, G.; Dei, M.; Lai, S.; Usala, G.; Lai, M.; Loi, P.; et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2006, 2, e132. [Google Scholar] [CrossRef] [PubMed]
  16. Benyamin, B.; Sørensen, T.I.A.; Schousboe, K.; Fenger, M.; Visscher, P.M.; Kyvik, K.O. Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome? Diabetologia 2007, 50, 1880–1888. [Google Scholar] [CrossRef] [PubMed]
  17. Cadby, G.; Melton, P.E.; McCarthy, N.S.; Giles, C.; Mellett, N.A.; Huynh, K.; Hung, J.; Beilby, J.; Dubé, M.-P.; Watts, G.F.; et al. Heritability of 596 lipid species and genetic correlation with cardiovascular traits in the Busselton Family Heart Study. J. Lipid Res. 2020, 61, 537–545. [Google Scholar] [CrossRef]
  18. Wang, W.; Zhang, C.; Liu, H.; Xu, C.; Duan, H.; Tian, X.; Zhang, D. Heritability and genome-wide association analyses of fasting plasma glucose in Chinese adult twins. BMC Genom. 2020, 21, 491. [Google Scholar] [CrossRef]
  19. Gjesing, A.P.; Hornbak, M.; Allin, K.H.; Ekstrøm, C.T.; Urhammer, S.A.; Eiberg, H.; Pedersen, O.; Hansen, T. High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients. Diabetologia 2014, 57, 1173–1181. [Google Scholar] [CrossRef]
  20. Kim, H.-J.; Seo, Y.-S.; Sung, J.; Son, H.-Y.; Yun, J.M.; Kwon, H.; Cho, B.; Kim, J.-I.; Park, J.-H. Interactions of CDH13 gene polymorphisms and ambient PM10 air pollution exposure with blood pressure and hypertension in Korean men. Chemosphere 2019, 218, 292–298. [Google Scholar] [CrossRef]
  21. Wang, M.; Zheng, S.; Nie, Y.; Weng, J.; Cheng, N.; Hu, X.; Ren, X.; Pei, H.; Bai, Y. Association between Short-Term Exposure to Air Pollution and Dyslipidemias among Type 2 Diabetic Patients in Northwest China: A Population-Based Study. Int. J. Environ. Res. Public Health 2018, 15, 631. [Google Scholar] [CrossRef] [PubMed]
  22. Hunter, D.J. Gene-environment interactions in human diseases. Nat. Rev. Genet. 2005, 6, 287–298. [Google Scholar] [CrossRef] [PubMed]
  23. Wu, Y.; Tian, Y.; Wang, M.; Wang, X.; Wu, J.; Wang, Z.; Hu, Y. Short-term exposure to air pollution and its interaction effects with two ABO SNPs on blood lipid levels in northern China: A family-based study. Chemosphere 2020, 249, 126120. [Google Scholar] [CrossRef] [PubMed]
  24. Peng, H.; Wang, M.; Wang, S.; Wang, X.; Fan, M.; Qin, X.; Wu, Y.; Chen, D.; Li, J.; Hu, Y.; et al. KCNQ1 rs2237892 polymorphism modify the association between short-term ambient particulate matter exposure and fasting blood glucose: A family-based study. Sci. Total Environ. 2023, 876, 162820. [Google Scholar] [CrossRef] [PubMed]
  25. Wang, S.; Wang, M.; Peng, H.; Tian, Y.; Guo, H.; Wang, J.; Yu, H.; Xue, E.; Chen, X.; Wang, X.; et al. Synergism of cell adhesion regulatory genes and instant air pollutants on blood pressure elevation. Chemosphere 2023, 312 Pt 1, 136992. [Google Scholar] [CrossRef] [PubMed]
  26. Poveda, A.; Chen, Y.; Brändström, A.; Engberg, E.; Hallmans, G.; Johansson, I.; Renstrom, F.; Kurbasic, A.; Franks, P.W. The heritable basis of gene-environment inter-actions in cardiometabolic traits. Diabetologia 2017, 60, 442–452. [Google Scholar] [CrossRef] [PubMed]
  27. Martin, L.J.; Kissebah, A.H.; Sonnenberg, G.E.; Blangero, J.; Comuzzie, A.G. Genotype-by-smoking interaction for leptin levels in the Metabolic Risk Complications of Obesity Genes project. Int. J. Obes. Relat. Metab. Disord. 2003, 27, 334–340. [Google Scholar] [CrossRef]
  28. Zheng, H.; Ye, Y.; Huang, H.; Huang, C.; Gao, W.; Wang, M.; Li, W.; Zhou, R.; Jiang, J.; Wang, S.; et al. A pedigree-based cohort to study the genetic risk factors for cardiometabolic diseases: Study design, baseline characteristics and preliminary results. Front. Public Health 2023, 11, 1189993. [Google Scholar] [CrossRef]
  29. Tian, Y.; Liu, H.; Zhao, Z.; Xiang, X.; Li, M.; Juan, J.; Song, J.; Cao, Y.; Wang, X.; Chen, L.; et al. Association between ambient air pollution and daily hospital admissions for ischemic stroke: A nationwide time-series analysis. PLoS Med. 2018, 15, e1002668. [Google Scholar] [CrossRef]
  30. Liu, C.; Henderson, B.H.; Wang, D.; Yang, X.; Peng, Z.R. A land use regression application into assessing spatial variation of in-tra-urban fine particulate matter (PM2.5) and nitrogen dioxide (NO2) concentrations in City of Shanghai, China. Sci. Total Environ. 2016, 565, 607–615. [Google Scholar] [CrossRef]
  31. Yang, B.-Y.; Bloom, M.S.; Markevych, I.; Qian, Z.; Vaughn, M.G.; Cummings-Vaughn, L.A.; Li, S.; Chen, G.; Bowatte, G.; Perret, J.L.; et al. Exposure to ambient air pollution and blood lipids in adults: The 33 Communities Chinese Health Study. Environ. Int. 2018, 119, 485–492. [Google Scholar] [CrossRef] [PubMed]
  32. Kim, K.-N.; Ha, B.; Seog, W.; Hwang, I.-U. Long-term exposure to air pollution and the blood lipid levels of healthy young men. Environ. Int. 2022, 161, 107119. [Google Scholar] [CrossRef] [PubMed]
  33. Wang, L.; Chen, G.; Pan, Y.; Xia, J.; Chen, L.; Zhang, X.; Silang, Y.; Chen, J.; Xu, H.; Zeng, C.; et al. Association of long-term exposure to ambient air pollutants with blood lipids in Chinese adults: The China Multi-Ethnic Cohort study. Environ. Res. 2021, 197, 111174. [Google Scholar] [CrossRef]
  34. Gui, Z.-H.; Yang, B.-Y.; Zou, Z.-Y.; Ma, J.; Jing, J.; Wang, H.-J.; Dong, G.-H.; Ma, Y.-H.; Guo, Y.-M.; Chen, Y.-J. Exposure to ambient air pollution and blood lipids in children and adolescents: A national population based study in China. Environ. Pollut. 2020, 266 Pt 3, 115422. [Google Scholar] [CrossRef] [PubMed]
  35. Tong, L.; Li, K.; Zhou, Q. The association between air pollutants and morbidity for diabetes and liver diseases modified by sexes, ages, and seasons in Tianjin, China. Environ. Sci. Pollut. Res. Int. 2015, 22, 1215–1219. [Google Scholar] [CrossRef] [PubMed]
  36. Raaschou-Nielsen, O.; Sørensen, M.; Ketzel, M.; Hertel, O.; Loft, S.; Tjønneland, A.; Overvad, K.; Andersen, Z.J. Long-term exposure to traffic-related air pollution and diabetes-associated mortality: A cohort study. Diabetologia 2013, 56, 36–46. [Google Scholar] [CrossRef]
  37. Eze, I.C.; Schaffner, E.; Fischer, E.; Schikowski, T.; Adam, M.; Imboden, M.; Tsai, M.; Carballo, D.; von Eckardstein, A.; Künzli, N.; et al. Long-term air pollution exposure and diabetes in a population-based Swiss cohort. Environ. Int. 2014, 70, 95–105. [Google Scholar] [CrossRef]
  38. Andersen, Z.J.; Raaschou-Nielsen, O.; Carstensen, B.; Hvidberg, M.; Jensen, S.S.; Ketzel, M.; Loft, S.; Tjønneland, A.; Overvad, K.; Sørensen, M. Diabetes incidence and long-term exposure to air pollution: A cohort study. Diabetes Care 2012, 35, 92–98. [Google Scholar] [CrossRef]
  39. Mao, S.; Chen, G.; Liu, F.; Li, N.; Wang, C.; Liu, Y.; Liu, S.; Lu, Y.; Xiang, H.; Guo, Y.; et al. Long-term effects of ambient air pollutants to blood lipids and dyslipidemias in a Chinese rural population. Environ. Pollut. 2020, 256, 113403. [Google Scholar] [CrossRef]
  40. Guo, Q.Y.; Zhao, L.Y.; He, Y.N.; Fang, Y.H.; Fang, H.Y.; Xu, X.L.; Jia, F.M.; Yu, D.M. Survey on dietary nutrients intake of Chinese residents between 2010 and 2012. Chin. J. Prev. Med. 2017, 51, 519–522. [Google Scholar]
  41. Sibai, A.M.; Tohme, R.A.; Almedawar, M.M.; Itani, T.; Yassine, S.I.; Nohra, E.A.; Isma’eel, H.A. Lifetime cumulative exposure to waterpipe smoking is associated with coronary artery disease. Atherosclerosis 2014, 234, 454–460. [Google Scholar] [CrossRef] [PubMed]
  42. Mirowsky, J.E.; Dailey, L.A.; Devlin, R.B. Differential expression of pro-inflammatory and oxidative stress mediators induced by nitrogen dioxide and ozone in primary human bronchial epithelial cells. Inhal. Toxicol. 2016, 28, 374–382. [Google Scholar] [CrossRef] [PubMed]
  43. Li, J.; Zhou, C.; Xu, H.; Brook, R.D.; Liu, S.; Yi, T.; Wang, Y.; Feng, B.; Zhao, M.; Wang, X.; et al. Ambient Air Pollution Is Associated with HDL (High-Density Lipoprotein) Dysfunction in Healthy Adults. Arter. Thromb. Vasc. Biol. 2019, 39, 513–522. [Google Scholar] [CrossRef] [PubMed]
  44. Zhang, K.; Wang, H.; He, W.; Chen, G.; Lu, P.; Xu, R.; Yu, P.; Ye, T.; Guo, S.; Li, S.; et al. The association between ambient air pollution and blood lipids: A longitudinal study in Shijiazhuang, China. Sci. Total Environ. 2021, 752, 141648. [Google Scholar] [CrossRef] [PubMed]
  45. Fantuzzi, G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005, 115, 911–999. [Google Scholar] [CrossRef] [PubMed]
  46. Brook, R.D.; Cakmak, S.; Turner, M.C.; Brook, J.R.; Crouse, D.L.; Peters, P.A.; van Donkelaar, A.; Villeneuve, P.J.; Brion, O.; Jerrett, M.; et al. Long-Term Fine Particulate Matter Exposure and Mortality From Diabetes in Canada. Diabetes Care 2013, 36, 3313–3320. [Google Scholar] [CrossRef] [PubMed]
  47. Lee, M.K.; The BIOS Consortium; Xu, C.-J.; Carnes, M.U.; Nichols, C.E.; Ward, J.M.; Kwon, S.O.; Kim, S.-Y.; Kim, W.J.; London, S.J. Genome-wide DNA methylation and long-term ambient air pollution exposure in Korean adults. Clin. Epigenetics 2019, 11, 37. [Google Scholar] [CrossRef]
  48. Plusquin, M.; Guida, F.; Polidoro, S.; Vermeulen, R.; Raaschou-Nielsen, O.; Campanella, G.; Hoek, G.; Kyrtopoulos, S.A.; Georgiadis, P.; Naccarati, A.; et al. DNA methylation and exposure to ambient air pollution in two prospective cohorts. Environ. Int. 2017, 108, 127–136. [Google Scholar] [CrossRef]
  49. Gruzieva, O.; Xu, C.-J.; Breton, C.V.; Annesi-Maesano, I.; Antó, J.M.; Auffray, C.; Ballereau, S.; Bellander, T.; Bousquet, J.; Bustamante, M.; et al. Epigenome-Wide Meta-Analysis of Methylation in Children Related to Prenatal NO2 Air Pollution Exposure. Environ. Health Perspect. 2017, 125, 104–110. [Google Scholar] [CrossRef]
Figure 1. Percentage changes with 95% confidence intervals (95% CIs) in blood lipids and FPG associated with per 1 μg/m3 increase in NO2 of different lag structures. Multivariable model was adjusted for age, sex, BMI, education level, family ID as a random effect term, physical activity, smoking, drinking, vegetable and fruit intake, whole-grain intake, meat intake, tea intake, the use of antihypertensive/antidiabetic/antihyperlipidemic drugs, and concentration of PM2.5, PM10, CO, and O3. HDLC, high-density lipoprotein cholesterol; Lag0, concentrations on the day of investigation; Lag1, concentrations on the day previous to investigation; Lag2, concentrations two days before investigation; LDLC, low-density lipoprotein cholesterol; Mv01, moving average concentrations of Lag0 and Lag1; Mv02, moving average concentrations of Lag0 to Lag2; TC, total cholesterol; TG, triglycerides.
Figure 1. Percentage changes with 95% confidence intervals (95% CIs) in blood lipids and FPG associated with per 1 μg/m3 increase in NO2 of different lag structures. Multivariable model was adjusted for age, sex, BMI, education level, family ID as a random effect term, physical activity, smoking, drinking, vegetable and fruit intake, whole-grain intake, meat intake, tea intake, the use of antihypertensive/antidiabetic/antihyperlipidemic drugs, and concentration of PM2.5, PM10, CO, and O3. HDLC, high-density lipoprotein cholesterol; Lag0, concentrations on the day of investigation; Lag1, concentrations on the day previous to investigation; Lag2, concentrations two days before investigation; LDLC, low-density lipoprotein cholesterol; Mv01, moving average concentrations of Lag0 and Lag1; Mv02, moving average concentrations of Lag0 to Lag2; TC, total cholesterol; TG, triglycerides.
Biology 12 01470 g001
Figure 2. Interactions effects of genotype with NO2 on blood lipid levels and fasting plasma glucose in different lag structures. Significant results are indicated with dark red patches and p values (p < 0.05). HDLC, high-density lipoprotein cholesterol; Lag0, concentrations on the day of investigation; Lag1, concentrations on the day previous to investigation; Lag2, concentrations two days before investigation; LDLC, low-density lipoprotein cholesterol; Mv01, moving average concentrations of Lag0 and Lag1; Mv02, moving average concentrations of Lag0 to Lag2; TC, total cholesterol; TG, triglycerides.
Figure 2. Interactions effects of genotype with NO2 on blood lipid levels and fasting plasma glucose in different lag structures. Significant results are indicated with dark red patches and p values (p < 0.05). HDLC, high-density lipoprotein cholesterol; Lag0, concentrations on the day of investigation; Lag1, concentrations on the day previous to investigation; Lag2, concentrations two days before investigation; LDLC, low-density lipoprotein cholesterol; Mv01, moving average concentrations of Lag0 and Lag1; Mv02, moving average concentrations of Lag0 to Lag2; TC, total cholesterol; TG, triglycerides.
Biology 12 01470 g002
Table 1. Characteristics of study participants.
Table 1. Characteristics of study participants.
Characteristic TotalMaleFemale
N (%) 1563 (100.00)681 (43.57)882 (56.43)
Age, mean (SD), y 57.23 (13.24)58.38 (12.97)56.35 (13.39)
BMI (kg/m2) 23.35 (3.36)23.40 (3.48)23.30 (3.26)
Smoking (%)Never1161 (74.3)304 (44.6)857 (97.2)
Current305 (19.5)283 (41.6)22 (2.5)
Previous97 (6.2)94 (13.8)3 (0.3)
Alcohol drinking (%)Never1360 (87.0)513 (75.3)847 (96.0)
Current166 (10.6)137 (20.1)29 (3.3)
Previous37 (2.4)31 (4.6)6 (0.7)
Physical activity, mean (SD), MET-h/week 63.34 (91.66)67.00 (99.95)60.51 (84.67)
Vegetable intake, mean (SD), g/d 228.00 (143.08)235.04 (156.41)222.56 (131.70)
Fruit intake, mean (SD), g/d 46.26 (67.59)41.74 (62.92)49.75 (70.83)
Meat intake, mean (SD), g/d 101.95 (71.72)112.95 (82.02)93.45 (61.33)
Whole-grain intake, mean (SD), g/d 11.12 (20.19)10.43 (20.60)11.66 (19.87)
TG, mean (SD), mmol/L1.75 (1.61)1.93 (1.82)1.61 (1.41)
TC mean (SD), mmol/L5.02 (1.89)4.81 (1.10)5.18 (2.30)
HDLC, mean (SD), mmol/L1.31 (0.60)1.20 (0.66)1.40 (0.53)
LDLC, mean (SD), mmol/L3.01 (0.81)2.96 (0.82)3.05 (0.80)
FPG, mean (SD), mmol/L5.64 (1.41)5.81 (1.65)5.50 (1.17)
BMI, body mass index; FPG, fasting plasma glucose; HDLC, high-density lipoprotein cholesterol; LDLC, low-density lipoprotein cholesterol; SD, standard deviation; TC, total cholesterol; TG, triglycerides.
Table 2. Summary statistics for NO2 concentrations (μg/m3).
Table 2. Summary statistics for NO2 concentrations (μg/m3).
Lag StructuresMean ± SDMinimumPercentileMaximumIQR
25th50th75th
Lag027.48 ± 12.058.0018.0026.0033.0068.0015.00
Lag127.45 ± 11.496.0019.0026.0033.0068.0014.00
Lag228.17 ± 11.189.0020.0026.0035.0068.0015.00
Mv0127.47 ± 11.227.0019.0027.5031.0065.0012.00
Mv0227.70 ± 10.647.6719.3329.3331.5065.0012.17
IQR, interquartile range; Lag0, concentrations on the day of investigation; Lag1, concentrations on day previous to investigation; Lag2, concentrations two days before investigation; Mv01, moving average concentrations of Lag0 and Lag1; Mv02, moving average concentrations of Lag0 to Lag2; SD, standard deviation.
Table 3. Percentage changes with 95% confidence intervals (95% CIs) in TG, TC, LDLC, HDLC, and FPG associated with per 1 μg/m3 increase in NO2 for different lag structures.
Table 3. Percentage changes with 95% confidence intervals (95% CIs) in TG, TC, LDLC, HDLC, and FPG associated with per 1 μg/m3 increase in NO2 for different lag structures.
TraitLag StructureModel 1Model 2Model 3Model 4
TGLag01.085 (0.634, 1.537)1.630 (1.149, 2.114)1.093 (0.657, 1.530)0.166 (−0.780, 1.121)
Lag11.175 (0.716, 1.636)1.660 (1.175, 2.146)0.711 (−0.122, 1.551)1.340 (0.857, 1.826)
Lag21.187 (0.727, 1.649)0.671 (−0.086, 1.433)1.394 (0.910, 1.881)1.505 (1.011, 2.001)
Mv010.098 (−0.574, 0.774)0.963 (0.535, 1.393)1.568 (1.071, 2.068)1.528 (1.032, 2.027)
Mv021.424 (0.954, 1.897)1.076 (0.642, 1.511)1.591 (1.092, 2.093)0.646 (−0.698, 2.008)
TCLag00.011 (−0.154, 0.177)0.107 (−0.067, 0.283)0.101 (−0.075, 0.277)0.140 (−0.259, 0.541)
Lag10.011 (−0.156, 0.178)0.101 (−0.073, 0.276)0.123 (−0.223, 0.470)0.086 (−0.101, 0.274)
Lag20.006 (−0.160, 0.173)0.160 (−0.142, 0.462)0.065 (−0.113, 0.244)0.084 (−0.105, 0.272)
Mv010.214 (−0.071, 0.500)0.100 (−0.075, 0.274)0.064 (−0.115, 0.244)0.081 (−0.107, 0.270)
Mv020.110 (−0.064, 0.284)0.095 (−0.081, 0.271)0.058 (−0.121, 0.237)0.284 (−0.286, 0.858)
LDLCLag00.108 (−0.004, 0.220)0.002 (−0.116, 0.119)0.022 (−0.098, 0.141)0.116 (−0.157, 0.390)
Lag10.097 (−0.015, 0.210)0.006 (−0.112, 0.124)0.196 (−0.040, 0.432)0.048 (−0.079, 0.175)
Lag20.093 (−0.020, 0.205)0.159 (−0.046, 0.365)0.058 (−0.062, 0.179)0.049 (−0.078, 0.176)
Mv010.221 (0.025, 0.417)0.014 (−0.105, 0.134)0.054 (−0.067, 0.175)0.044 (−0.083, 0.172)
Mv020.005 (−0.113,0.123)0.025 (−0.094, 0.145)0.049 (−0.072, 0.171)0.020 (−0.373, 0.414)
HDLCLag0−0.680 (−0.898, −0.461)−0.363 (−0.579, −0.146)−0.369 (−0.585, −0.153)−1.926 (−2.421, −1.428)
Lag1−0.674 (−0.894, −0.453)−0.371 (−0.587, −0.155)−0.479 (−0.881, −0.076)−0.558 (−0.796, −0.320)
Lag2−0.683 (−0.904, −0.463)−0.872 (−1.261, −0.481)−0.577 (−0.806, −0.347)−0.560 (−0.799, −0.320)
Mv01−1.896 (−2.275, −1.516)−0.340 (−0.553, −0.126)−0.573 (−0.803, −0.342)−0.573 (−0.812, −0.332)
Mv02−0.364 (−0.579, −0.148)−0.354 (−0.569, −0.139)−0.582 (−0.813, −0.352)−1.540 (−2.232, −0.843)
GLULag00.331 (−0.104, 0.768)0.117 (−0.334, 0.570)0.158 (−0.303, 0.621)1.400 (0.341, 2.470)
Lag10.274 (−0.165, 0.715)0.126 (−0.326, 0.580)0.798 (−0.114, 1.718)0.049 (−0.437, 0.538)
Lag20.265 (−0.174, 0.706)0.080 (−0.693, 0.859)0.143 (−0.321, 0.609)0.010 (−0.480, 0.503)
Mv011.163 (0.403, 1.929)0.147 (−0.309, 0.604)0.093 (−0.374, 0.562)0.001 (−0.490, 0.494)
Mv020.085 (−0.362, 0.535)0.153 (−0.307, 0.615)0.083 (−0.385, 0.553)0.861 (−0.641, 2.386)
HDLC, high-density lipoprotein cholesterol; Lag0, concentrations on the day of investigation; Lag1, concentrations on the day previous to investigation; Lag2, concentrations two days before investigation; LDLC, low-density lipoprotein cholesterol; Mv01, moving average concentrations of Lag0 and Lag1; Mv02, moving average concentrations of Lag0 to Lag2; TC, total cholesterol; TG, triglycerides. Model 1 adjusted for age, sex, BMI, education level, and family ID; Model 2 additionally adjusted for physical activity, smoking, drinking, vegetable and fruit intake, whole-grain intake, meat intake, and tea consumption on the basis of model 1; Model 3 additionally adjusted for use of antihypertensive/antidiabetic/antihyperlipidemic drugs on the basis of model 2; Model 4 additionally adjusted for concentration of PM2.5, PM10, CO, and O3. Significant results are indicated in bold (p < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Guo, H.; Wang, M.; Ye, Y.; Huang, C.; Wang, S.; Peng, H.; Wang, X.; Fan, M.; Hou, T.; Wu, X.; et al. Short-Term Exposure to Nitrogen Dioxide Modifies Genetic Predisposition in Blood Lipid and Fasting Plasma Glucose: A Pedigree-Based Study. Biology 2023, 12, 1470. https://doi.org/10.3390/biology12121470

AMA Style

Guo H, Wang M, Ye Y, Huang C, Wang S, Peng H, Wang X, Fan M, Hou T, Wu X, et al. Short-Term Exposure to Nitrogen Dioxide Modifies Genetic Predisposition in Blood Lipid and Fasting Plasma Glucose: A Pedigree-Based Study. Biology. 2023; 12(12):1470. https://doi.org/10.3390/biology12121470

Chicago/Turabian Style

Guo, Huangda, Mengying Wang, Ying Ye, Chunlan Huang, Siyue Wang, Hexiang Peng, Xueheng Wang, Meng Fan, Tianjiao Hou, Xiaoling Wu, and et al. 2023. "Short-Term Exposure to Nitrogen Dioxide Modifies Genetic Predisposition in Blood Lipid and Fasting Plasma Glucose: A Pedigree-Based Study" Biology 12, no. 12: 1470. https://doi.org/10.3390/biology12121470

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop